Quantcast

Latest Clinical trial Stories

2014-09-24 08:28:14

New addition expands WCG's eClinical offerings for improving clinical trial start-up and management PRINCETON, N.J., Sept. 24, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies. Based near Philadelphia, PA, ePS is a leading provider of eClinical solutions and technology-enabled services that improve the conduct of...

2014-09-23 23:01:00

PhUSE, the biggest membership driven community in the biometrical sector of the pharmaceutical industry, continues its global expansion and organizes single day events which will be held this fall in Japan, China and India. (PRWEB) September 24, 2014 The inaugural single day event in Japan will be held October 31st in the Hotel New Otani Tokyo Gardens in Tokyo. Clinical data scientists will meet and discuss various topics about standard data implementation and validation. The second...

2014-09-23 08:30:43

Enrollment in Worldwide Trial Continues as Planned REDMOND, Wash., Sept. 23, 2014 /PRNewswire/ -- Cerevast Therapeutics Inc., a privately held medical technology company, announced today the outcome of the first interim analysis of its ongoing Phase 3 clinical trial evaluating the Company's proprietary Clotbust ER(TM) ultrasonic headframe for the treatment of acute ischemic stroke. The independent Data Safety Monitoring Board (DSMB) has recommended the trial continue enrollment as...

2014-09-23 04:21:52

CAMBRIDGE, England, September 23, 2014 /PRNewswire/ -- New spin-out from Cancer Research UK launched with funding from Imperial Innovations, Cambridge Innovation Capital and Johnson & Johnson Development Corporation Inivata, a clinical cancer genomics company focused on harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment, today announced it has raised GBP4m in a funding round led by Imperial Innovations...

2014-09-22 12:31:25

PINE BROOK, N.J., Sept. 22, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, today announced it has completed three phase 3 healthy adult volunteer safety studies of obiltoxaximab (ETI-204). Obiltoxaximab is an anti-toxin in development for the treatment of inhalational anthrax and data from these studies support the safety and tolerability of the antitoxin when administered intravenously...

2014-09-22 08:28:29

Reaccreditation underscores WIRB-Copernicus Group's commitment to enhancing safeguards for clinical trial participants PRINCETON, N.J., Sept. 22, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that its Western Institutional Review Board(®) (WIRB) has been reaccredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), which endeavors...

2014-09-22 08:28:21

BRIDGEWATER, N.J., Sept. 22, 2014 /PRNewswire/ -- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today is pleased to announce that TUV-SUD and The Medicinal Evaluation Board of the Netherlands (MEB) has granted its request for a label expansion for Neutrolin, its catheter lock solution. Neutrolin was initially approved in July 2013 for use...

2014-09-22 08:28:17

SAN DIEGO, Sept. 22, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at the NewsMakers in the Biotech Industry conference on Friday, September 26, 2014, at 11:30 a.m. Eastern Time (8:30 a.m. Pacific Time), at the Millennium Broadway Hotel in New York City. A live audio webcast of the presentation will be available under the investor relations section of Arena's website at...

2014-09-22 08:26:16

TOORAK, Australia, Sept. 22, 2014 /PRNewswire/ -- Antisense Therapeutics (the "Company" or "ANP") is pleased to report the publication of previously generated Phase IIa clinical trial data on ATL1102 in the medical journal Neurology. The article titled "CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS", is currently available online and will be included in the print edition Volume 83, November 11, 2014. The article highlights the...

2014-09-19 08:25:37

--Use of Crowdsourced Clinical Trial Protocols and Telemonitoring for Remote Patient Data Collection Is Potential Game-Changer for Orphan Diseases NEW YORK, Sept. 19, 2014 /PRNewswire/ -- Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it is applying its expertise in crowdsourcing and digital telemonitoring technology to conduct a clinical trial of Auven Therapeutics' Kiacta(TM)( )in...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related